Dacheng attorneys advise biotechnologies company on NEEQ listing
A team of attorneys from Dacheng’s Wuhan office has advised Ferguson (Wuhan) Biotechnologies on its application for a listing at the NEEQ system.
On 9 January 2014, National Equities Exchange and Quotations, or NEEQ, issued a letter of approval to Ferguson (Wuhan) Biotechnologies on its application for a listing at the NEEQ system.
This made Ferguson (Wuhan) one of the first foreign-invested joint stock companies entering the system following the expansion of the new third board.
The Dacheng team comprising attorneys Zhao Xuejun, Xu Qiang and Huang Jing conducted due diligence, provided equity restructuring counselling and made listing-related materials for the client.
News from Dacheng
News from The Lawyer
Briefings from Dacheng
China’s updated company law took effect on 1 March. Leo Zhou Liang, senior partner at Dacheng, highlights the key changes for corporates.
Dacheng has published the first issue of its Tax Newsletter, edited by David Yu, Lily Fan, Fidel Liu and Shen Liming.